ResMed (RMD) operating expenses was $1.5B in FY2026 (+13% YoY). The tables below show the complete quarterly and annual operating expenses history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Expenses
Fiscal Year
Operating Expenses
YoY
2026
$1.5B
+13%
2025
$1.4B
+8%
2024
$1.3B
+5%
2023
$1.2B
+19%
2022
$1.0B
+10%
2021
$927M
+2%
2020
$908M
-0%
2019
$912M
+18%
2018
$775M
+1%
2017
$764M
+21%
2016
$631M
+5%
2015
$602M
+4%
2014
$578M
-1%
2013
$586M
+11%
2012
$526M
+11%
2011
$474M
+14%
2010
$415M
+14%
2009
$363M
Recent Quarterly Operating Expenses
Quarter
Operating Expenses
Q2 2026
$413M
Q1 2026
$391M
Q4 2025
$381M
Q3 2025
$358M
Q2 2025
$366M
Q1 2025
$340M
Q4 2024
$334M
Q3 2024
$330M
Q2 2024
$334M
Q1 2024
$318M
Q4 2023
$308M
Q3 2023
$311M
Source: RMD on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.